CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Takeda Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Takeda Pharmaceutical Co Ltd
4F, 2-1-1, Nihombashihon-cho
Phone: +81 332782111p:+81 332782111 CHUO-KU, TKY  103-8668  Japan Ticker: 45024502
Business Summary
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023YesYes-YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of Board of Directors, Independent Director MasamiIijima 72 6/29/2022 6/1/2021
President, Chief Executive Officer, Representative Director ChristopheWeber 56 4/1/2015 6/27/2014
Chief Financial Officer, Director CostaSaroukos 52 6/1/2019 6/1/2019
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Jerini AG 5 Riverwalk Dublin Ireland
Shire Ltd Miesian Plaza DUBLIN Ireland
Shire Ltd (ADR) Miesian Plaza DUBLIN Ireland
26 additional Subsidiary records available in full report.

Business Names
Business Name
0A87
0RN3
4502
106 additional Business Names available in full report.

General Information
Number of Employees: 49,095 (As of 3/31/2023)
Outstanding Shares: 1,568,932,227 (As of 3/31/2024)
Shareholders: 545,808
Stock Exchange: TYO
Fax Number: +81 332782000


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024